Feng Xue

2.3k total citations · 1 hit paper
70 papers, 1.4k citations indexed

About

Feng Xue is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Feng Xue has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Feng Xue's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Feng Xue is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Feng Xue collaborates with scholars based in China, United States and United Kingdom. Feng Xue's co-authors include Ning Xu, Conghuan Shen, Kexin Liu, Junjie Gao, Yiwei Chen, Miao Yu, Guangyi Li, Changqing Zhang, Bin Zhu and Junhui Yin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Feng Xue

66 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression

2022 317 citations Miao Yu, Yiwei Chen et al. EBioMedicine profile →

Peers

Countries citing papers authored by Feng Xue

Since Specialization

Citations

This map shows the geographic impact of Feng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xue more than expected).

Fields of papers citing papers by Feng Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xue. The network helps show where Feng Xue may publish in the future.

Co-authorship network of co-authors of Feng Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Xue. A scholar is included among the top collaborators of Feng Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Xue. Feng Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China 2025 ·Frontiers in Public Health ·Fangfang Chen, Feng Xue, Xiao Li, Hong Tang, S. Joe Qin, Jie Peng, (unknown)	0
2	The challenges and countermeasures of college students' ideological and political course education under the background of big data 2024 ·Feng Xue, (unknown)	1
3	ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer 2024 ·Cancer Management and Research ·Bin Liu, Bingtian Zhao, Yan Yin, Yan Jiang, Feng Xue, Lei Wang, (unknown), Guangxin Liu, (unknown), (unknown)	2
4	EP.07C.13 Aumolertinib as Adjuvant Therapy in Postoperative EGFR-Mutated Stage I NSCLC with Multiple High-Risk Factors 2024 ·Journal of Thoracic Oncology ·Qingchen Wu, Ming Ni, Feng Xue, Xiaoping Wu, Tian Jiang	0
5	The path of ideological and political education in fulfilling the function of psychological nurturing 2024 ·Frontiers in Psychology ·Feng Xue, (unknown), (unknown)	3
6	GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism 2022 ·BioMed Research International ·Ping Wan, Yuchen Hou, Bijun Qiu, Mingxuan Feng, Taihua Yang, Yi Luo, (unknown), Xiaosong Chen, Jianjun Zhang, Feng Xue, Qiang Xia	1
7	Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression breakdown → 2022 ·EBioMedicine ·Miao Yu, Yiwei Chen, Feng Xue, Kexin Liu, Bin Zhu, Junjie Gao, Junhui Yin, Changqing Zhang, Guangyi Li	317
8	Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy 2021 ·Cell Transplantation ·Tianyi Wang, Mingxuan Feng, (unknown), Xinyu Wan, Ci Pan, Jingyan Tang, Feng Xue, Minzhi Yin, (unknown), Qiang Xia, Benshang Li, Jing Chen	19
9	Multiple microRNAs regulate tacrolimus metabolism through CYP3A5 2020 ·Pharmacological Research ·(unknown), Dan Tang, Ping Wan, Tian Qin, Taihua Yang, Ji Wu, Hao Ji, Jinchuan Liu, Feng Xue, Yuanjia Tang, Qiang Xia	7
10	A novel long noncoding RNA PGC1β-OT1 regulates adipocyte and osteoblast differentiation through antagonizing miR-148a-3p 2019 ·Cell Death and Differentiation ·Hairui Yuan, Xiaowei Xu, Feng Xue, Endong Zhu, Jie Zhou, Guannan Wang, (unknown), Baoli Wang	45
11	Research Advances in the Function of the High-affinity K+ Transporter (HKT) Proteins and Plant Salt Tolerance 2018 ·Chinese Bulletin of Botany ·(unknown), (unknown), Feng Xue, (unknown)	1
12	Current Antioxidant Treatments in Organ Transplantation 2016 ·Oxidative Medicine and Cellular Longevity ·Shaojun Shi, Feng Xue	43
13	Identification of a novel nuclear-localized adenylate kinase 6 from Arabidopsis thaliana as an essential stem growth factor 2012 ·Plant Physiology and Biochemistry ·Feng Xue, (unknown), Xiaofeng Zheng, (unknown)	19
14	Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell 2012 ·Biochemical and Biophysical Research Communications ·Ning Xu, Jianjun Zhang, Conghuan Shen, Yi Luo, Lei Xia, Feng Xue, Qiang Xia	164
15	Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell 2012 ·Biochemical and Biophysical Research Communications ·Ning Xu, Conghuan Shen, Yi Luo, Lei Xia, Feng Xue, Qiang Xia, Jianjun Zhang	112
16	Living donor liver transplantation in 43 children with biliary atresia: a single-center experience from the mainland of China 2012 ·Hepatobiliary & pancreatic diseases international ·(unknown), Qiang Xia, Jianjun Zhang, Feng Xue, Xiaosong Chen, Qigen Li, Ning Xu	9
17	Invasive fungal infection after liver transplantation: Risk factors and significance of immune cell function monitoring 2011 ·Journal of Digestive Diseases ·Tao Zhou, Feng Xue, (unknown), (unknown), (unknown), Ning Xu, Jianjun Zhang, Qiang Xia	24
18	Clinical data and CT findings of pulmonary infection caused by different pathogens after kidney transplantation 2011 ·European Journal of Radiology ·Tao Jiang, Feng Xue, Xuan Zheng, Hong Yu, (unknown), Xiangsheng Xiao, (unknown)	10
19	Inhibitory Effect of Small Interfering RNA Targeting Insulin-Like Growth Factor-I Receptor in Ovarian Cancer OVCAR3 Cells 2010 ·Cancer Biotherapy and Radiopharmaceuticals ·Yuan An, Yan Cai, (unknown), Liying Cai, Yang Yang‐Hartwich, Feng Xue, Jianhua Zheng	13
20	Over Expression of NM23-H1、DJ1 and TIM1 in Poor Differential Nasopharyngeal Carcinoma Tissues and CNE2 Cell Line 2005 ·PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS ·Feng Xue	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact